Menu
Back to User profile » Dr Kristina S Boye
Papers published by Dr Kristina S Boye:
The Impact of Substantial Improvements in HbA1c and Weight Loss on the Medication Preferences of People with Type 2 Diabetes
Gelhorn HL, Osumili B, Brown K, Ross MM, Schulz A, Fernandez G, Boye KS
Patient Preference and Adherence 2023, 17:793-805
Published Date: 22 March 2023
Treatment-Related Attributes of Diabetes Therapies and How People with Type 2 Diabetes Report Their Impact on Indicators of Medication-Taking Behaviors
Sims TJ, Boye KS, Robinson S, Kennedy-Martin T
Patient Preference and Adherence 2022, 16:1919-1939
Published Date: 4 August 2022
The Benefits of Safely Achieving Near Normoglycemia from the Perspective of People with Type 2 Diabetes: A Quantitative Survey Study
Gelhorn HL, Ross MM, Shinde S, Thieu VT, Boye KS
Patient Preference and Adherence 2022, 16:1897-1906
Published Date: 3 August 2022
Evaluating the Impact of Therapy on Quality of Life in Type 2 Diabetes: A Literature Review of Utilities Associated with Treatment-Related Attributes
Valentine W, Norrbacka K, Boye KS
Patient Related Outcome Measures 2022, 13:97-111
Published Date: 12 May 2022
Weight Change and the Association with Adherence and Persistence to Diabetes Therapy: A Narrative Review
Boye KS, Shinde S, Kennedy-Martin T, Robinson S, Thieu VT
Patient Preference and Adherence 2022, 16:23-39
Published Date: 6 January 2022
Patient-Reported Outcomes and Impact of Type 2 Diabetes: A Cross-Sectional Study in the Kingdom of Saudi Arabia
Gelhorn HL, Boye KS, Shalhoub H, Matza LS, Jordan JB, Alhammad A, Anand SB, Ekhzaimy AA, Strizek A
Patient Preference and Adherence 2020, 14:2231-2242
Published Date: 10 November 2020
Patient preferences for glucagon-like peptide-1 receptor–agonist treatment attributes
Thieu VT, Robinson S, Kennedy-Martin T, Boye KS, Garcia-Perez LE
Patient Preference and Adherence 2019, 13:561-576
Published Date: 17 April 2019
Patient preferences in Italy: health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes
Matza LS, Boye KS, Jordan JB, Norrbacka K, Gentilella R, Tiebout AR, Browne C, Orsini Federici M, Biricolti G, Stewart KD
Patient Preference and Adherence 2018, 12:971-979
Published Date: 6 June 2018
Cost of medication adherence and persistence in type 2 diabetes mellitus: a literature review
Kennedy-Martin T, Boye KS, Peng X
Patient Preference and Adherence 2017, 11:1103-1117
Published Date: 30 June 2017
Evaluating health-related quality of life in type 1 diabetes: a systematic literature review of utilities for adults with type 1 diabetes
Smith-Palmer J, Bae JP, Boye KS, Norrbacka K, Hunt B, Valentine WJ
ClinicoEconomics and Outcomes Research 2016, 8:559-571
Published Date: 7 October 2016
Associations between adherence and outcomes among older, type 2 diabetes patients: evidence from a Medicare Supplemental database
Boye KS, Curtis SE, Lage MJ, Garcia-Perez LE
Patient Preference and Adherence 2016, 10:1573-1581
Published Date: 16 August 2016
Evaluating preferences for profiles of glucagon-like peptide-1 receptor agonists among injection-naive type 2 diabetes patients in Japan
Gelhorn HL, Bacci ED, Poon JL, Boye KS, Suzuki S, Babineaux SM
Patient Preference and Adherence 2016, 10:1337-1348
Published Date: 25 July 2016
Evaluating preferences for profiles of GLP-1 receptor agonists among injection-naïve type 2 diabetes patients in the UK
Gelhorn HL, Poon JL, Davies EW, Paczkowski R, Curtis SE, Boye KS
Patient Preference and Adherence 2015, 9:1611-1622
Published Date: 9 November 2015
Burden and management of chronic kidney disease in Japan: systematic review of the literature
Travers K, Martin A, Khankhel Z, Boye KS, Lee LJ
International Journal of Nephrology and Renovascular Disease 2013, 6:1-13
Published Date: 3 January 2013